Mannkind (MNKD) Current Deferred Revenue (2014 - 2026)
Mannkind (MNKD) reported Current Deferred Revenue of $11.5 million for Q1 2026, down 1.97% year-over-year from $11.8 million in Q1 2025, and down 24.83% quarter-over-quarter from $15.3 million in Q4 2025.
Mannkind (MNKD) Current Deferred Revenue (2014 - 2026) Analysis & Trends
Mannkind (MNKD) has 13 years of Current Deferred Revenue data on file, last reported at $11.5 million in Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $11.5 million, down 1.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.5 million (down 1.97% YoY), and the FY2025 annual result was $15.3 million, up 23.57% from the prior year.
- Current Deferred Revenue retreated to $11.5 million in Q1 2026 per MNKD's latest filing, from $15.3 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $78.9 million in Q4 2023 and troughed at $1.3 million in Q1 2022.
- A 5-year average of $19.1 million and a median of $10.1 million in 2025 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue sank 94.95% in 2022, then soared 5829.61% in 2023.
- A 5-year view of Current Deferred Revenue shows it stood at $63.6 million in 2022, then increased by 24.09% to $78.9 million in 2023, then tumbled by 84.27% to $12.4 million in 2024, then climbed by 23.57% to $15.3 million in 2025, then decreased by 24.83% to $11.5 million in 2026.
- Business Quant data shows MNKD's Current Deferred Revenue at $11.5 million in Q1 2026, $15.3 million in Q4 2025, and $10.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.53 Mn |
| Dec 31, 2025 | 15.33 Mn |
| Sep 30, 2025 | 10.12 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Mar 31, 2025 | 11.76 Mn |
| Dec 31, 2024 | 12.41 Mn |
| Sep 30, 2024 | 6.52 Mn |
| Jun 30, 2024 | 7.42 Mn |
| Mar 31, 2024 | 7.60 Mn |
| Dec 31, 2023 | 78.88 Mn |
| Sep 30, 2023 | 3.67 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Mar 31, 2023 | 77.50 Mn |
| Dec 31, 2022 | 63.57 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 1.67 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 20.37 Mn |
| Sep 30, 2021 | 14.02 Mn |
| Jun 30, 2021 | 20.13 Mn |